首页> 外文期刊>The New Microbiologica >Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species
【24h】

Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species

机译:卡泊芬净对念珠菌非白色念珠菌药敏试验中微量稀释法和E检验程序的比较

获取原文
获取原文并翻译 | 示例
           

摘要

It is widely known that systemic and mucosal candidiasis caused by Candida non-albicans strains endangers the lives of hospitalised patients since these pathogens are extremely difficult to defeat by commonly used antifungal agents. The present study determined the in vitro activities of a novel antimicotic drug - caspofungin - against 76 Candida non-albicans isolates by means of the CLSI reference method for broth dilution antifungal susceptibility testing of yeasts and the E-test procedure for comparison. Caspofungin was efficacious against the majority of strains tested, with the average MICs90, evaluated by the microdilution method and E-tests amounting to 1 me and 0.5 mg/l, respectively Since the agreement between MICs within +/- 2 dilutions obtained by these two techniques was 92% (Kappa coefficient of 0.92), the E-test procedure seems to be a reliable alternative to the broth microdilution method and may provide another choice for clinical laboratories.
机译:众所周知,由念珠菌非白色念珠菌引起的全身性和粘膜念珠菌病危及住院患者的生命,因为这些病原体非常难以被常用的抗真菌剂所杀死。本研究通过CLSI参考方法对酵母进行肉汤稀释抗真菌药敏试验,并通过E-test程序确定了一种新型抗微生物药物caspofungin对76株假丝酵母念珠菌的体外活性。卡泊芬净对大多数测试菌株有效,通过微稀释法评估的平均MIC 90和E检验分别为1 me和0.5 mg / l,因为这两种化合物在+/- 2稀释度内MIC的一致性技术为92%(卡帕系数为0.92),E检验程序似乎是肉汤微量稀释法的可靠替代方法,可能为临床实验室提供另一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号